-
acquisition of Corixa. GSK had
formerly made use of the Corixa's MPL (
Monophosphoryl lipid A, a
derivative of the
lipid A molecule), an
adjuvant in some...
- The
adjuvant part is AS01E, a
combination of QS-21, cholesterol, and
monophosphoryl lipid A (MPL). It was
initially developed by GSK plc and
funded by non-profits...
-
syndrome Medial patellar luxation, a
medical condition in dogs
Monophosphoryl lipid A, a
derivative of the
lipid A
molecule Microsoft Public License...
-
nanoparticle vaccine adjuvanted with Army
Liposome Formulation containing monophosphoryl lipid A and QS-21: a
phase 1, randomised, double-blind, placebo-controlled...
- L1
protein 20
micrograms AS04 adjuvant, containing: 3-O-desacyl-4'-
monophosphoryl lipid A (MPL) 50
micrograms adsorbed on
aluminium hydroxide, hydrated...
- 18,
expressed in
insect cells, and is
adjuvanted with 3-O-Desacyl-4-
monophosphoryl lipid (MPL) A and
aluminum hydroxide. The
first VLP
vaccine that addresses...
- two
plant saponins from
Quillaja saponaria, a
Chilean soap bark tree.
Monophosphoryl lipid A (MPL), a
detoxified version of the
lipopolysaccharide from the...
-
papillomavirus (HPV) vaccine. It
consists of
aluminium hydroxide and
monophosphoryl lipid A (MPL). It is the
successor of AS03, a
squalene based adjuvant...
-
adjuvants such as
aluminum hydroxide (Alhydrogel),
saponin QS-21, and
monophosphoryl lipid A (MPL) in squalene/lecithin/Tween 80
emulsion (SLT). One dose...
- cells. The AS01B
adjuvant suspension is
composed of 3-O-desacyl-4'-
monophosphoryl lipid A (MPL) from
Salmonella (Minnesota strain) and a
saponin molecule...
